Equities
  • Price (EUR)53.70
  • Today's Change0.600 / 1.13%
  • Shares traded850.00
  • 1 Year change+146.90%
  • Beta--
Data delayed at least 15 minutes, as of Feb 12 2026 18:31 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Exosens SAS is a France-based company which is a manufacturer and seller of technologies in the field of particles and photo detection and imaging intended to serve space, research, defense and commercial clients. The Company designs, produces and markets electro-optic components and devices including sensors and optics for the detection and amplification of low light, radiation, and emissions. It offers detectors and detection solutions: such as travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors and light intensifier tubes to respond to complex issues in environment.

  • Revenue in EUR (TTM)431.70m
  • Net income in EUR55.73m
  • Incorporated2021
  • Employees1.42k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EXENS:PAR since
announced
Transaction
value
PHASICS SAAnnounced27 Aug 202527 Aug 2025Announced38.28%--
Data delayed at least 15 minutes, as of Feb 12 2026 16:35 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.